MALIGNANT NEOPLASM OF BREAST
Clinical trials for MALIGNANT NEOPLASM OF BREAST explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT NEOPLASM OF BREAST trials appear
Sign up with your email to follow new studies for MALIGNANT NEOPLASM OF BREAST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested in fight against tough cancers
Disease control OngoingThis study is testing a new combination of two drugs, selumetinib and olaparib, for people with advanced solid tumors that have returned or spread. The first goal is to find the highest dose of the drug pair that patients can safely tolerate. If a safe dose is found, the study wi…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists test 'Bacterial Bomb' to blast open tough tumors
Disease control OngoingThis early-stage study is testing a new combination treatment for advanced solid tumors that have stopped responding to standard therapies. Researchers are injecting a modified, non-toxic bacteria directly into a tumor to help break it down, while also giving an immunotherapy dru…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
Can a phone app calm nerves before cancer chemo? new study investigates
Symptom relief OngoingThis study is testing whether a short, daily mind-body exercise program delivered through a phone app can help reduce stress and physical symptoms for women newly diagnosed with breast cancer. About 62 participants were randomly assigned to either use the app for 14 days before s…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Symptom relief
Last updated Mar 27, 2026 12:38 UTC
-
Swedish cancer registry tracks 1,500 patients on common treatment
Knowledge-focused OngoingThis study aims to understand how Swedish patients with advanced breast cancer are using the drug palbociclib in everyday medical care. It will observe about 1,500 adult patients who have been prescribed this medication, tracking how long they stay on treatment and their health o…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
Researchers track Real-Life results of popular breast cancer drug
Knowledge-focused OngoingThis study looks at how the breast cancer drug palbociclib is actually used in everyday medical practice and what results patients experience. Researchers will analyze anonymous medical records of adults with advanced hormone-positive breast cancer who started treatment between 2…
Matched conditions: MALIGNANT NEOPLASM OF BREAST
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 17, 2026 13:08 UTC